Skip to main content
OpenTrials

Clinical trial condition

Fragile X Syndrome

Explore clinical trials studying Fragile X Syndrome. Study availability and eligibility vary by location and protocol.

77 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Fragile X Syndrome trial results

Completed

Biomarker and DNA Collection in Subjects Participating in Protocol 22003

NCT00892580

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • University of California-Los Angeles Neuropsychiatric Institute Los Angeles, California, United States
  • Yale Child Study Center New Haven, Connecticut, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View Trial Details
Completed

Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome

NCT01282268

Conditions
Autism Spectrum Disorder, Child Development Disorders, Pervasive, Chromosome Disorders, +14 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • Miller Children's Hospital Research Administration Long Beach, California, United States
  • University of California-Davis, M.I.N.D. Institute Sacramento, California, United States
  • Psychiatric Centers at San Diego San Diego, California, United States
View all 24 locations
View Trial Details
Completed

Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome

NCT00788073

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • University of California-Los Angeles Neuropsychiatric Institute Los Angeles, California, United States
  • M.I.N.D. Institute Sacramento, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details

Related conditions